Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/604171


Croatia Pharmaceuticals and Healthcare Report Q2 2008


Description: The Croatia Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Croatias pharmaceuticals and healthcare industry.

The Croatian pharmaceutical market has developed strongly in the past decade, but remains small in regional terms, given the limitations posed by the small population size. Generics, mostly of the relatively expensive branded variety, account for over 70% of the total prescription market by value. The use of novel and more expensive pharmaceuticals is hampered by healthcare debts, cost-containment initiatives and the support for the strong domestic generics industry in the face of distinct intellectual property (IP) deficiencies. In the coming years, however, regulatory and healthcare service improvements, as well as the increasing number of prescriptions, are set to gradually facilitate market entry for such products, especially as Croatian European Union (EU) membership talks reach later stages.

Generally speaking, the forecast period will witness a continued dominance of prescription medicines, although over-the-counter (OTC) drugs are rapidly gaining prominence, boosted by marketing and information campaigns. Value growth of the sector will, however, remain influenced by the fact that Croatian consumers are extremely price-conscious, although vitamins and dietary products in particular are likely to beat the trend, supported by lifestyle changes.

Similarly, the demand for medical devices is expected to increase in coming years, in line with healthcare system modernisation, economic development and the entering of further stages of integration into the EU and the wider European community. While the price of devices is still a crucial factor in terms of their placement on the market, the rising prominence of the private diagnostic sector will also stimulate the growth of the medical equipment sector in Croatia.

In the new Q208 Business Environment Rankings for the major 15 Central and Eastern Europe (CEE) markets, Croatia’s position remains unchanged. The country, which shares twelfth place with Lithuania, is placed higher than only Ukraine and Serbia, indicating that the Croatian pharmaceutical market is one of the least desirable investment destinations in the region due to its small size and spending per capita, among other limiting factors. However, the pending accession of Croatia into the EU is already improving market conditions for novel drugs, thus in particular benefiting multinationals. In the meantime, the dominant local player, Pliva, is undergoing extensive strategy realignment following its acquisition by US Barr Laboratories, divesting of its operations in non-key markets, such as Italy and Spain, as well as of its animal business in the past year. Having purchased a German oncology specialist O.R.C.A.pharm, Pliva can be expected to make similar purchases in its main European markets.


Contents: Executive Summary
Croatia Pharmaceuticals Industry SWOT
Croatia Political SWOT
Croatia Economic SWOT
Croatia Business Environment SWOT
Pharmaceutical Business Environment Ratings
Table: Central And Eastern Europe Pharmaceutical Business Environment Rankings
Limits Of Potential Returns
Risks To Realisation Of Returns
Croatia - Market Sum
Regulatory Regime
Table: Croatian Product Approvals In 2006
Intellectual Property Regime
Pricing Regime
Reimbursement Regime
Recent Pricing And Reimbursement Developments
Table: Recently Approved Medicines In Croatia
Industry Trends And Developments
Health Status
Table: Leading Causes Of Death In Croatia, 2005
Healthcare Provision
Healthcare Expenditure
Healthcare Debts
Healthcare Reforms
Domestic Pharmaceutical Industry
Domestic Company Activity
Foreign Company Activities
Table: Lukaps’ Time Line
Pharmaceutical Retail
Research And Development Sector
Medical Devices
Industry Forecast Sce
Overall Market Forecast
Table: Croatia’s Drug Market Indicators, 2006-2012
Key Growth Factors - Industry
Table: Croatian Health Expenditure Trends, 2006-2012
Key Growth Factors - Macroeconomic
Table: Croatia - Economic Activity
Patented Market Forecast
Table: Croatia’s Patented Market Indicators, 2006-2012
Generics Market Forecast
Table: Croatia’s Generics Market Indicators, 2006-2012
OTC Market Forecast
Table: Croatia’s OTC Market, 2006-2012 (US$mn unless otherwise stated)
Export/Import Forecasts
Table: Croatia’s Pharmaceutical Trade Figures, 2006-2012 (US$mn)
Other Healthcare Forecasts
Table: Other Healthcare Indicators For Croatia, 2006-2012
Key Risks To our Forecast Scenario
Competitive Landscape
Company Monitor
International Company Profiles
GlaxoSmithKline
Pfizer
Sanofi-Aventis
Novartis
Merck & Co
Krka
Indigenous Company Profiles
Pliva
Belupo
Our Forecast Modelling

How We Generate Our Industry Forecasts
Pharmaceutical Industry.
Pharmaceutical Business Environment Ratings Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Weighting
Table: Weighting Of Components
Sources


Companies Mentioned - Belupo - GlaxoSmithKline - Krka - Merck & Co - Novartis - Pfizer - Pliva - Sanofi-Aventis


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/604171

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 16/02/2012 04:13:14
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Croatia Pharmaceuticals and Healthcare Report Q2 2008
Web Address:
http://www.researchandmarkets.com/reports/604171
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €393.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 16/02/2012 04:13:14

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)